← Back to Search

Cognitive-Behavioral Therapy for Disruptive Behavior in Children and Adolescents (RDoC-CBT Trial)

N/A

Waitlist Available

Led By Denis G. Sukhodolsky, Ph.D.

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up follow up (3 months)

Awards & highlights

RDoC-CBT Trial Summary

This trial will study whether CBT is better than SPT for treating disruptive behavior in kids and adolescents, by looking at brain activity before and after treatment.

Eligible Conditions

Noncompliance
Aggression
Disruptive Behavior
Anger
Irritability

RDoC-CBT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ follow up (3 months)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~follow up (3 months)

This trial's timeline: 3 weeks for screening, Varies for treatment, and follow up (3 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Modified Overt Aggression Scale

The Clinical Global Impression - Improvement Score

Secondary outcome measures

The Child Behavior Checklist

Other outcome measures

Electroencephalography (EEG)

functional magnetic resonance imaging (fMRI)

RDoC-CBT Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Cognitive-Behavioral Therapy for Anger and Aggressive BehaviorExperimental Treatment1 Intervention

CBT is a behavioral intervention that consists of 12 weekly sessions. During CBT children are taught various skills for coping with frustration and parents are taught various strategies for managing situations that can be anger provoking for their child.

Group II: Supportive Psychotherapy (SPT)Active Control1 Intervention

SPT consists of 12 sessions that are focused on discussing peer relationships and family functioning with a goal of enhancing subjective well-being

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Cognitive-Behavioral Therapy for Anger and Aggression

2013

N/A

~110

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor

1,847 Previous Clinical Trials

2,737,567 Total Patients Enrolled

5 Trials studying Aggression

287 Patients Enrolled for Aggression

National Institute of Mental Health (NIMH)NIH

2,783 Previous Clinical Trials

2,689,048 Total Patients Enrolled

7 Trials studying Aggression

903 Patients Enrolled for Aggression

Denis G. Sukhodolsky, Ph.D.Principal InvestigatorYale University

Media Library

Cognitive-Behavioral Therapy for Anger and Aggression Clinical Trial Eligibility Overview. Trial Name: NCT01965184 — N/A

Aggression Clinical Trial 2023: Cognitive-Behavioral Therapy for Anger and Aggression Highlights & Side Effects. Trial Name: NCT01965184 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there room for additional participants in this clinical experiment?

"Per the information located on clinicaltrials.gov, this investigation is not presently recruiting participants as it was last updated in January of 2022. Even though individuals cannot join this trial anymore, 184 other studies are actively seeking out candidates at the moment."

Answered by AI

Are geriatric individuals being included in the current experiment?

"This study accepts participants aged between 8 and 16 years old."

Answered by AI

What are the criteria for inclusion in this research endeavor?

"Candidates for this clinical trial must demonstrate aggression and fall between 8-16 years of age. Currently, there are 101 slots open to join the experiment."

Answered by AI